| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2001 | US6187813 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 02/13/2001 | US6187811 Methods for treating benign prostatic hyperplasia using tocotrienols |
| 02/13/2001 | US6187810 Administering to improve the therapeutic effect and the bioavailability of known medicaments; administering to diminish acute or chronic toxicity of a natural alkaloid, cardiac glycoside or synthetic drug |
| 02/13/2001 | US6187809 Beta-3 adrenaline receptor agonist drugs for the treatment of diabetes, obesity, and hyperlipemia; 2-(n-(2-(dibenzofuran-3-yloxy)ethyl)amino)-1-phenylethanol, for example |
| 02/13/2001 | US6187807 Methods of use and compositions of (S) (-)-amisulpride |
| 02/13/2001 | US6187806 N-linked sulfone of heterocyclic thioester hair growth compositions and uses |
| 02/13/2001 | US6187805 Indole and indoline derivatives as 5-HT6 selective ligands |
| 02/13/2001 | US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate |
| 02/13/2001 | US6187802 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 02/13/2001 | US6187800 Method for the prevention and treatment of mastitis |
| 02/13/2001 | US6187799 Inhibition of raf kinase activity using aryl ureas |
| 02/13/2001 | US6187798 Heterocyclic compounds |
| 02/13/2001 | US6187796 Alopecia treatment; immunophilin affinity |
| 02/13/2001 | US6187795 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 02/13/2001 | US6187794 Administering as antiasthmatic agent; side effect reduction |
| 02/13/2001 | US6187793 Psychosis, schizophrenia; antiallergens |
| 02/13/2001 | US6187792 Compounds with analgesic effect |
| 02/13/2001 | US6187791 Method of providing an antihistaminic effect in a hepatically impaired patient |
| 02/13/2001 | US6187790 Use of cilostazol for treatment of sexual dysfunction |
| 02/13/2001 | US6187789 Muscle relaxants for emergency intubation and surgery |
| 02/13/2001 | US6187786 Antitumor and anticarcinogenic agents |
| 02/13/2001 | US6187785 Administering hydrogenated pyrido(4,3-b)indole derivatives such as dimebolin to treat alzheimer*s disease |
| 02/13/2001 | US6187784 Pipecolic acid derivative hair growth compositions and uses |
| 02/13/2001 | US6187783 Antitumor agents |
| 02/13/2001 | US6187782 Morphinane derivatives and medicinal use thereof |
| 02/13/2001 | US6187779 Administering antitumor agents to treat colon cancer |
| 02/13/2001 | US6187778 4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists |
| 02/13/2001 | US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents |
| 02/13/2001 | US6187776 Heterocyclic compounds and their use |
| 02/13/2001 | US6187775 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 02/13/2001 | US6187772 Pyrroloazepine compounds |
| 02/13/2001 | US6187769 Benzoxazepine derivatives and their salts and medicaments containing the same |
| 02/13/2001 | US6187767 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 02/13/2001 | US6187766 Steroid sulphatase inhibitors |
| 02/13/2001 | US6187765 Mometasone furoate suspensions for nebulization |
| 02/13/2001 | US6187763 Containing petrolatum solid oil, squalane liquid oil, ionic polysaccharide and nonionic surfactant |
| 02/13/2001 | US6187762 Fucoside containing polymer |
| 02/13/2001 | US6187758 Anthracycline glycosides |
| 02/13/2001 | US6187756 Composition and methods for treatment of neurological disorders and neurodegenerative diseases |
| 02/13/2001 | US6187755 Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 02/13/2001 | US6187752 Method for treating schizophrenia employing an ace inhibitor |
| 02/13/2001 | US6187745 Co-administration of a pentosan polysulfate (pps) or a pharmaceutically acceptable salt thereof. |
| 02/13/2001 | US6187695 Uniformly distributed surface deposits of a chemical composition that contains an oil, a wax, and preferably a fatty alcohol. suitable compositions include those which have a melting point of 30-70 degrees c. |
| 02/13/2001 | US6187587 Nucleotide sequences; for diagnosis and treatment of related disorders |
| 02/13/2001 | US6187586 Nucleotide sequence of compound which inhibits expression of human serine/threonine kinase involved in signal transduction; diagnosis, prophylaxis, and therapy of related diseases |
| 02/13/2001 | US6187568 Culture product of actinoplane; immunosuppressant, fungicides, antitumor agents |
| 02/13/2001 | US6187545 Oligonucleotide sequences associated with the suppression of the activity of phosphenolpyruvate carboxykinase |
| 02/13/2001 | US6187533 Screening for genome adjustments associated with non-insulin dependent diabetes; obtaining nucleotide sequences from human, analyze nucleotide sequences for genome adjustment, presence of genome adjustment indicates genetic disorders |
| 02/13/2001 | US6187347 Coagulation of blood from wounds |
| 02/13/2001 | US6187345 Flutamide compositions and preparations |
| 02/13/2001 | US6187343 Multistage mixing, micronization, rotation and separation |
| 02/13/2001 | US6187342 Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt |
| 02/13/2001 | US6187341 Trovafloxacin mesylate tablet |
| 02/13/2001 | US6187339 Solid pharmaceutical composition comprising an excipient capable of binding water |
| 02/13/2001 | US6187336 Process for producing a solid which is rapidly soluble in the oral cavity |
| 02/13/2001 | US6187334 Low methoxyl pectin, sodium alginates and acids, carrageenan and gellan gum |
| 02/13/2001 | US6187333 Antidiabetic agents |
| 02/13/2001 | US6187332 Killing rhinovirus in human nose |
| 02/13/2001 | US6187331 Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D |
| 02/13/2001 | US6187327 Contains 2,4,4'-trichloro-2'-hydroxydiphenyl ether as the antimicrobial agent |
| 02/13/2001 | US6187323 The use of this composition as a reservoir of active ingredients in a transdermal release system. |
| 02/13/2001 | US6187315 Compositions and methods of treating cancer with tannin complexes |
| 02/13/2001 | US6187314 Provide a more accurately defined ginkgo biloba extract by further identifying individual components of the flavonoid compounds, determining the amount of the individual components and regulating the ratio among them. |
| 02/13/2001 | US6187312 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of infectious diseases |
| 02/13/2001 | US6187304 Effects of IFN-γ on cardiac hypertrophy |
| 02/13/2001 | US6187296 Such as alpha-difluoromethyl lysine (deml) or alpha-monofluoromethyl lysine (mfml) |
| 02/13/2001 | CA2280316A1 Transdermal, oral and intravenous formulations of 2,3-dimethoxy-5-methyl-6-dacaprenyl-1,4-benzoquinone |
| 02/13/2001 | CA2280253A1 Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone |
| 02/13/2001 | CA2203942C A pyrrolidylthiocarbapenem derivative |
| 02/13/2001 | CA2192674C Methods for treating respiratory disease |
| 02/13/2001 | CA2190753C Anti-acne compositions |
| 02/13/2001 | CA2189830C Uses for corticotropin releasing factor atagonists |
| 02/13/2001 | CA2180977C Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
| 02/13/2001 | CA2170065C Amide-derived bi-aromatic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
| 02/13/2001 | CA2147808C Acetylenic biaromatic compounds containing an adamantyl group; pharmaceutical and cosmetic compositions containing them and uses thereof |
| 02/13/2001 | CA2147806C Polyenic compounds; pharmaceutical and cosmetic compositions containing them and uses |
| 02/13/2001 | CA2130339C Antibacterial coated medical implants |
| 02/13/2001 | CA2106176C Neutral lipids from kernel of job's tears |
| 02/13/2001 | CA2059288C Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties |
| 02/13/2001 | CA2054895C 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation |
| 02/13/2001 | CA2048619C Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 02/13/2001 | CA2044317C Hair restorer |
| 02/13/2001 | CA2021501C Topical pharmaceutical compositions |
| 02/13/2001 | CA2016505C Water soluble high molecular polymerized drug preparation |
| 02/13/2001 | CA2012876C Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances |
| 02/13/2001 | CA2012046C Use of 5'-deoxy-5'-methylthioadenosine, s-adenosylmethionine and their salts for reducing seborrhea |
| 02/13/2001 | CA2012045C Pharmaceutical compositions containing 5'-deoxy-5'- methylthioadenosine, s-adenosylmethionine and their salts for hair growth in subjects suffering baldness |
| 02/13/2001 | CA2006713C Packaged anti-plaque oral compositions |
| 02/13/2001 | CA2001203C Novel antimicrobial dithiocarbamoyl quinolones |
| 02/12/2001 | CA2314915A1 Peroxovanadium compounds as protein tyrosine phosphate (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune response |
| 02/12/2001 | CA2280249A1 Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production |
| 02/09/2001 | CA2315594A1 Process for the preparation of aqueous formulations for ophthalmic use |
| 02/08/2001 | WO2001009616A2 Method for determining physiological effects of hemoglobin |
| 02/08/2001 | WO2001009390A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | WO2001009379A1 Antisense modulation of pepck-mitochondrial expression |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | WO2001009298A2 Strategy for carbohydrate-based cancer vaccines |
| 02/08/2001 | WO2001009189A2 Compositions and methods for the treatment of tumors |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |